Orrick Advises Cerba HealthCare in Acquisition of Lifebrain


Orrick’s Attilio Mazzilli led a team that assisted Cerba HealthCare, a leader in outpatient diagnostics, in the agreement for the acquisition of the entire stake of Lifebrain from Global Healthcare Services Sàrl, an independently managed investment company of Investindustrial. Lifebrain is one of the largest Italian providers in clinical laboratory testing in the fields of clinical chemistry, haematology, immunochemistry, microbiology, molecular biology, cytology and pathology.

The transaction is expected to be completed by the end of the second half of 2021 and is subject to customary approvals from antitrust authorities.

In addition to Attilio, the Orrick team included Livia Maria Pedroni, Alessandro Vittoria, Sarah Lo Piparo, Elena Cozzupoli, Francesca Isgrò, Pietro Merlino, Scott Morrison, Elisabetta Santo, Ivan Rotunno, Michele Bertani, Alessia Ciranna, Edoardo Mencacci, Giuseppe Cuminetti, Giulia Rivarola di Roccella, Martina Acquaro, Federico Perego, Rosario Apuzzo, Leonardo Sicco, Andrea Alfonso Stigliano, Pietro Parrocchetti, Marianna Meriani, and Richard Hunt.